Skip to Content

Why collect data? 

We value data and have strict measures in place to uphold the privacy of every person who gives permission for their clinical information to be input into the CF Registry. Here’s why we collect data: 

  • To conduct research investigating differences in health outcomes within the population, benefits of newborn screening, survival post-transplant, among many others. 
  • To advocate for more funding and resources in support of CF clinics. 
  • To educate, promote awareness and increase knowledge about CF. 
  • To support clinical care, respond to emerging healthcare issues, monitor epidemiological trends and implement quality improvement initiatives 

A history of the Canadian CF Registry 

  • 1978 First joint US-Canada CF Registry Report is published  
  • 1984 Independent CF Registry is established and managed by Cystic Fibrosis Canada 
  • 1988 Study using CF Registry data supports high-fat diet that becomes global standard in CF care 
  • 1991 After the discovery of the CF gene in 1989, CF Registry begins tracking genotype 
  • 2008 Electronic submission of data begins 
  • 2015 Updated web-based platform launches with improved functionality and features 
  • 2016 Study co-authored by Cystic Fibrosis Canada using CF Registry data reveals benefit of newborn screening for CF in Canada 
  • Future: Develop digital health tools to improve efficiencies  

Applying to use Registry data

Canadian CF Registry data can be made available for research and clinical study purposes following a formal request to Cystic Fibrosis Canada and pending the review and approval from the Registry Review Panel. There may be a fee associated with the administration, extraction and analysis of the data depending on the nature of the request.

Questions? Contact us at cfregistry@cysticfibrosis.ca